1. Natural compounds for endometriosis and related chronic pelvic pain: A review.
- Author
-
Zaurito A, Mehmeti I, Limongelli F, Zupo R, Annunziato A, Fontana S, and Tardugno R
- Subjects
- Humans, Female, Animals, Chronic Pain drug therapy, Curcumin therapeutic use, Curcumin pharmacology, Ginsenosides pharmacology, Ginsenosides therapeutic use, Ginsenosides isolation & purification, Phytochemicals pharmacology, Polyphenols pharmacology, Polyphenols therapeutic use, Oxidative Stress drug effects, Endometriosis drug therapy, Pelvic Pain drug therapy, Biological Products pharmacology, Biological Products therapeutic use
- Abstract
Endometriosis is a chronic gynecological disorder characterized by significant chronic pelvic pain (CPP) and infertility, adversely affecting the quality of life for many women worldwide. This review aims to synthesize recent findings on natural bioactive compounds derived from various plant sources that exhibit beneficial effects in the management of endometriosis and related CPP. A thorough search of databases, including PubMed, Scopus, and Google Scholar, was conducted to identify studies evaluating the efficacy of natural compounds on endometriosis and related CPP. In alphabetical order, curcumins, ginsenosides, polyphenols and other secondary metabolites showed promising effects on oxidative stress, inflammation, and pain modulation associated with endometriosis acting on multiple pathways. Most of the selected articles were in vitro and in vivo studies in animal models, with a limited number of clinical trials. The reported natural compounds according to the highlighted multiple bioactivities, might be valuable complementary alternatives as supplements, nutraceuticals, or in advanced personalized nutrition. Further clinical investigations are needed to comprehensively evaluate their therapeutic potential, safety, efficacy and to establish effective treatment protocols., Competing Interests: Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF